Skip Navigation

Cardiovascular Research 2001 51(1):41-50; doi:10.1016/S0008-6363(01)00272-3
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ueda, H.
Right arrow Articles by Nakamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueda, H.
Right arrow Articles by Nakamura, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats

Hideki Uedaa,b, Teruya Nakamuraa,b, Kunio Matsumotoa, Yoshiki Sawab, Hikaru Matsudab and Toshikazu Nakamuraa,*

aDivision of Biochemistry, Biomedical Research Center, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan
bFirst Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan

* Corresponding author. Tel.: +81-6-6879-3783; fax: +81-6-6879-3789 nakamura{at}onbich.med.osaka-u.ac.jp

Objective: Cardiotrophic growth factors with anti-cell death actions on cardiac myocytes have gained attention for treatment of patients with myocardial infarction. Hepatocyte growth factor (HGF) plays a role in tissue repair and protection from injuries, however, the physiological role of HGF in the myocardium has not been well defined. We asked if HGF would afford to the infarcted myocardium. Methods and results: Mature cardiac myocytes prepared from adult rats expressed barely detectable levels of the c-Met/HGF receptor, however, c-Met receptor expression increased during cultivation, which meant that cardiac myocytes are potential targets of HGF. Addition of hydrogen peroxide remarkably decreased the number of viable mature cardiac myocytes in primary culture, whereas treatment with HGF enhanced survival of the cells subjected to the oxidant stress. Although very low levels of c-Met/HGF receptor and HGF mRNA expression were seen in normal rat hearts, both c-Met/HGF receptor and HGF mRNA levels rapidly increased to much higher levels than normal, when the rats were subjected to myocardial infarction. Immunohistochemical analysis of the c-Met receptor indicated that this receptor was expressed in cardiomyocytes localized in the border regions of the viable myocardium and in non-infarcted regions following myocardial infarction. Conclusion: The c-Met/HGF receptor is induced in cardiomyocytes following myocardial infarction and HGF exhibits protective effect on cardiomyocytes against oxidative stress. Our working hypothesis is that HGF may afford myocardial protection from myocardial infarction.

KEYWORDS Coronary disease; Infarction; Growth factors; Myocytes; Signal transduction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. Okada, T. R. Payne, B. Zheng, H. Oshima, N. Momoi, K. Tobita, B. B. Keller, J. A. Phillippi, B. Peault, and J. Huard
Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium
J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1869 - 1880.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. A. Gude, G. Emmanuel, W. Wu, C. T. Cottage, K. Fischer, P. Quijada, J. A. Muraski, R. Alvarez, M. Rubio, E. Schaefer, et al.
Activation of Notch-Mediated Protective Signaling in the Myocardium
Circ. Res., May 9, 2008; 102(9): 1025 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
X. Li, Z. Wang, H. Ran, X. Li, Q. Yuan, Y. Zheng, J. Ren, L. Su, W. Zhang, Q. Li, et al.
Experimental Research on Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor Directed by Ultrasound-Targeted Microbubble Destruction in Rats
J. Ultrasound Med., March 1, 2008; 27(3): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Esaki, G. Takemura, K.-i. Kosai, T. Takahashi, S. Miyata, L. Li, K. Goto, R. Maruyama, H. Okada, H. Kanamori, et al.
Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1048 - H1057.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Urbanek, M. Rota, S. Cascapera, C. Bearzi, A. Nascimbene, A. De Angelis, T. Hosoda, S. Chimenti, M. Baker, F. Limana, et al.
Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival
Circ. Res., September 30, 2005; 97(7): 663 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Shirakawa, Y. Sawa, Y. Takewa, E. Tatsumi, Y. Kaneda, Y. Taenaka, and H. Matsuda
Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 624 - 632.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Tambara, G. U. Premaratne, G. Sakaguchi, N. Kanemitsu, X. Lin, H. Nakajima, Y. Sakakibara, Y. Kimura, M. Yamamoto, Y. Tabata, et al.
Administration of Control-Released Hepatocyte Growth Factor Enhances the Efficacy of Skeletal Myoblast Transplantation in Rat Infarcted Hearts by Greatly Increasing Both Quantity and Quality of the Graft
Circulation, August 30, 2005; 112(9_suppl): I-129 - I-134.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Sakaguchi, K. Tambara, Y. Sakakibara, M. Ozeki, M. Yamamoto, G. Premaratne, X. Lin, K. Hasegawa, Y. Tabata, K. Nishimura, et al.
Control-Released Hepatocyte Growth Factor Prevents the Progression of Heart Failure in Stroke-Prone Spontaneously Hypertensive Rats
Ann. Thorac. Surg., May 1, 2005; 79(5): 1627 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Futamatsu, J.-i. Suzuki, S. Mizuno, N. Koga, S. Adachi, H. Kosuge, Y. Maejima, K. Hirao, T. Nakamura, and M. Isobe
Hepatocyte Growth Factor Ameliorates the Progression of Experimental Autoimmune Myocarditis: A Potential Role for Induction of T Helper 2 Cytokines
Circ. Res., April 29, 2005; 96(8): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
K. Nakamura, S. Hirohata, T. Murakami, T. Miyoshi, K. Demircan, T. Oohashi, H. Ogawa, K. Koten, K. Toeda, S. Kusachi, et al.
Dynamic Induction of ADAMTS1 Gene in the Early Phase of Acute Myocardial Infarction
J. Biochem., October 1, 2004; 136(4): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Yamaura, K.-i. Ito, K. Tsukioka, Y. Wada, A. Makiuchi, M. Sakaguchi, T. Akashima, M. Fujimori, Y. Sawa, R. Morishita, et al.
Suppression of Acute and Chronic Rejection by Hepatocyte Growth Factor in a Murine Model of Cardiac Transplantation: Induction of Tolerance and Prevention of Cardiac Allograft Vasculopathy
Circulation, September 21, 2004; 110(12): 1650 - 1657.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Kondo, K. Ohmori, A. Oshita, H. Takeuchi, S. Fuke, K. Shinomiya, T. Noma, T. Namba, and M. Kohno
Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 644 - 653.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Li, G. Takemura, K.-i. Kosai, K. Yuge, S. Nagano, M. Esaki, K. Goto, T. Takahashi, K. Hayakawa, M. Koda, et al.
Postinfarction Treatment With an Adenoviral Vector Expressing Hepatocyte Growth Factor Relieves Chronic Left Ventricular Remodeling and Dysfunction in Mice
Circulation, May 20, 2003; 107(19): 2499 - 2506.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kitta, R. M. Day, Y. Kim, I. Torregroza, T. Evans, and Y. J. Suzuki
Hepatocyte Growth Factor Induces GATA-4 Phosphorylation and Cell Survival in Cardiac Muscle Cells
J. Biol. Chem., February 7, 2003; 278(7): 4705 - 4712.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Jin, R. Yang, W. Li, A. K. Ogasawara, R. Schwall, D. A. Eberhard, Z. Zheng, D. Kahn, and N. F. Paoni
Early Treatment with Hepatocyte Growth Factor Improves Cardiac Function in Experimental Heart Failure Induced by Myocardial Infarction
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 654 - 660.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. S. Malatino, A. Cataliotti, F. A. Benedetto, B. Stancanelli, I. Bellanuova, P. Belluardo, L. Bonaiuto, G. Tripepi, F. Mallamaci, P. Castellino, et al.
Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease
Hypertension, January 1, 2003; 41(1): 88 - 92.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. M.C. Dixon
Help from within: cardioprotective properties of hepatocyte growth factor
Cardiovasc Res, July 1, 2001; 51(1): 4 - 6.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.